Ads
related to: new blood pressure procedure fda
Search results
Results from the WOW.Com Content Network
(Reuters) - The U.S. Food and Drug Administration on Friday approved the use of Medtronic's treatment device in a surgery called renal denervation in patients whose high blood pressure cannot be ...
A new FDA-approved treatment for high blood pressure targeting the nerves of the kidneys has been studied in Austin and is now being done at the Heart Hospital of Austin. On March 27, the hospital ...
(Reuters) - The U.S. Food and Drug Administration (FDA) approved the use of a device made by an Otsuka Holdings unit in a type of surgery to treat high blood pressure, the company said on Wednesday.
This was often successful in reducing blood pressure but due to its non-selective nature the side effects of the procedure were poorly tolerated. Side effects included orthostatic hypotension, palpitations, anhydrosis, intestinal disturbances, loss of ejaculation, thoracic duct injuries and atelectasis. [ 10 ]
Baroreflex activation therapy is an approach to treating high blood pressure and the symptoms of heart failure. It uses an implanted device to electrically stimulate baroreceptors in the carotid sinus region. This elicits a reflex response through the sympathetic and vagal nervous systems that reduces blood pressure.
Moxonidine is a new-generation alpha-2/imidazoline receptor agonist antihypertensive drug licensed for the treatment of mild to moderate essential hypertension. [5] [6] It may have a role when thiazides, beta-blockers, ACE inhibitors, and calcium channel blockers are not appropriate or have failed to control blood pressure.
Ads
related to: new blood pressure procedure fda